Lasa Supergenerics Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 305.56 million compared to INR 288.79 million a year ago. Revenue was INR 305.6 million compared to INR 28.87 million a year ago.

Net loss was INR 49.5 million compared to INR 120.84 million a year ago. Basic loss per share from continuing operations was INR 0.99 compared to INR 2.97 a year ago. Diluted loss per share from continuing operations was INR 0.99 compared to INR 2.97 a year ago.